What are TransMedics Group, Inc.'s profit margins?

TransMedics Group, Inc. (TMDX) runs a 59.1% gross margin and a 14.9% operating margin, with a 27.0% net margin.

Where do TransMedics Group, Inc.'s ratios come from?

Every ratio is computed from TransMedics Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

TransMedics Group, Inc. TMDX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	59.9%+0.6pp	59.4%-4.4pp	63.8%-6.1pp	69.8%-0.1pp
Operating margin	17.9%+9.4pp	8.5%+21.5pp	-13%+20.7pp	-33.6%+96.7pp
Net margin	31.4%+23.4pp	8%—	——	-38.8%+107pp
Returns
Return on equity	54.2%+34.8pp	19.4%—	——	-28.4%+23.1pp
Efficiency
Asset turnover	0.6×+0.1×	0.6×+0.1×	0.5×0.0×	0.5×+0.2×
Liquidity
Current ratio	7.1×-1.2×	8.3×-1.0×	9.3×-1.4×	10.7×+5.6×
Leverage
Debt-to-equity	0.1×-0.2×	0.3×-0.2×	0.5×+0.1×	0.4×-0.3×
Net debt / EBITDA	-3.1×+1.6×	-4.7×—	——	——
Per Share
Book value per share	$11.67+79.8%	$6.49+53.8%	$4.22-33.4%	$6.34+158%
Valuation
Market capitalization	$4.16B+98.7%	$2.09B-18.8%	$2.58B+30.8%	$1.97B+270%
Price / earnings	21.8×-37.2×	59×—	——	——
Price / sales	6.9×+2.1×	4.7×-5.9×	10.7×-10.4×	21.1×+3.5×
Price / book	8.8×-0.4×	9.2×-9.6×	18.8×+8.3×	10.5×+2.7×
EV / EBITDA	27.5×-4.3×	31.9×—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about TransMedics Group, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are TransMedics Group, Inc.'s profit margins?: TransMedics Group, Inc. (TMDX) runs a 59.1% gross margin and a 14.9% operating margin, with a 27.0% net margin.
Where do TransMedics Group, Inc.'s ratios come from?: Every ratio is computed from TransMedics Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.